SH3BP5 and diffuse large B-cell lymphoma: By leveraging SH3BP5’s unique metabolic-immune regulatory functions—such as its dependence on mitochondrial OXPHOS and its role in modulating the immunosuppressive TME—this integrative approach significantly strengthens the biological relevance of DLBCL subtype classification.